1
|
Scully C and Felix DH: Oral medicine -
update for the dental practitioner oral cancer. Br Dent J.
200:13–17. 2006. View Article : Google Scholar : PubMed/NCBI
|
2
|
Bello IO, Soini Y and Salo T: Prognostic
evaluation of oral tongue cancer: Means, markers and perspectives
(II). Oral Oncol. 46:636–643. 2010. View Article : Google Scholar : PubMed/NCBI
|
3
|
Hannigan GE, Leung-Hagesteijn C,
Fitz-Gibbon L, Coppolino MG, Radeva G, Filmus J, Bell JC and Dedhar
S: Regulation of cell adhesion and anchorage-dependent growth by a
new beta 1-integrin-linked protein kinase. Nature. 379:91–96. 1996.
View Article : Google Scholar : PubMed/NCBI
|
4
|
Zervas CG, Psarra E, Williams V, Solomon
E, Vakaloglou KM and Brown NH: A central multifunctional role of
integrin-linked kinase at muscle attachment sites. J Cell Sci.
124:1316–1327. 2011. View Article : Google Scholar : PubMed/NCBI
|
5
|
Hannigan G, Troussard AA and Dedhar S:
Integrin-linked kinase: A cancer therapeutic target unique among
its ILK. Nat Rev Cancer. 5:51–63. 2005. View Article : Google Scholar : PubMed/NCBI
|
6
|
Somasiri A, Howarth A, Goswami D, Dedhar S
and Roskelley CD: Overexpression of the integrin-linked kinase
mesenchymally transforms mammary epithelial cells. J Cell Sci.
114:1125–1136. 2001.PubMed/NCBI
|
7
|
Wu C, Keightley SY, Leung-Hagesteijn C,
Radeva G, Coppolino M, Goicoechea S, McDonald JA and Dedhar S:
Integrin-linked protein kinase regulates fibronectin matrix
assembly, E-cadherin expression, and tumorigenicity. J Biol Chem.
273:528–536. 1998. View Article : Google Scholar : PubMed/NCBI
|
8
|
Nawshad A, Lagamba D, Polad A and Hay ED:
Transforming growth factor-β signaling during
epithelial-mesenchymal transformation: Implications for
embryogenesis and tumor metastasis. Cells Tissues Organs.
179:11–23. 2005. View Article : Google Scholar
|
9
|
Foroni C, Broggini M, Generali D and Damia
G: Epithelial-mesenchymal transition and breast cancer: Role,
molecular mechanisms and clinical impact. Cancer Treat Rev.
38:689–697. 2012. View Article : Google Scholar
|
10
|
Li R, Liu B, Yin H, Sun W, Yin J and Su Q:
Overexpression of integrin-linked kinase (ILK) is associated with
tumor progression and an unfavorable prognosis in patients with
colorectal cancer. J Mol Histol. 44:183–189. 2013. View Article : Google Scholar
|
11
|
Li J, Yang ZL, Ren X, Zou Q, Yuan Y, Liang
L, Chen M and Chen S: ILK and PRDX1 are prognostic markers in
squamous cell/adenosquamous carcinomas and adenocarcinoma of
gallbladder. Tumour Biol. 34:359–368. 2013. View Article : Google Scholar
|
12
|
Chen D, Zhang Y, Zhang X, Li J, Han B, Liu
S, Wang L, Ling Y, Mao S and Wang X: Overexpression of
integrin-linked kinase correlates with malignant phenotype in
non-small cell lung cancer and promotes lung cancer cell invasion
and migration via regulating epithelial-mesenchymal transition
(EMT)-related genes. Acta Histochem. 115:128–136. 2013. View Article : Google Scholar
|
13
|
Watzka SB, Setinek U, Stubenberger EB,
Tötsch M, Dekan G, Marcher M, Fleck T and Müller MR:
Integrin-linked kinase, phosphorylated AKT and the prognosis of
malignant pleural mesothelioma. Eur J Cardiothorac Surg.
39:180–184. 2011. View Article : Google Scholar
|
14
|
Serrano I, McDonald PC, Lock FE and Dedhar
S: Role of the integrin-linked kinase (ILK)/Rictor complex in
TGFβ-1-induced epithelial-mesenchymal transition (EMT). Oncogene.
32:50–60. 2013. View Article : Google Scholar
|
15
|
Becker-Santos DD, Guo Y, Ghaffari M,
Vickers ED, Lehman M, Altamirano-Dimas M, Oloumi A, Furukawa J,
Sharma M, Wang Y, et al: Integrin-linked kinase as a target for
ERG-mediated invasive properties in prostate cancer models.
Carcinogenesis. 33:2558–2567. 2012. View Article : Google Scholar : PubMed/NCBI
|
16
|
Yan Z, Yin H, Wang R, Wu D, Sun W, Liu B
and Su Q: Overexpression of integrin-linked kinase (ILK) promotes
migration and invasion of colorectal cancer cells by inducing
epithelial-mesenchymal transition via NF-κB signaling. Acta
Histochem. 116:527–533. 2014. View Article : Google Scholar
|
17
|
Liang F, Zhang S, Wang B, Qiu J and Wang
Y: Overexpression of integrin-linked kinase (ILK) promotes glioma
cell invasion and migration and down-regulates E-cadherin via the
NF-κB pathway. J Mol Histol. 45:141–151. 2014. View Article : Google Scholar
|
18
|
Zhao D, Tang XF, Yang K, Liu JY and Ma XR:
Over-expression of integrin-linked kinase correlates with aberrant
expression of Snail, E-cadherin and N-cadherin in oral squamous
cell carcinoma: Implications in tumor progression and metastasis.
Clin Exp Metastasis. 29:957–969. 2012. View Article : Google Scholar : PubMed/NCBI
|
19
|
Zhao G, Guo LL, Xu JY, Yang H, Huang MX
and Xiao G: Integrin-linked kinase in gastric cancer cell
attachment, invasion and tumor growth. World J Gastroenterol.
17:3487–3496. 2011. View Article : Google Scholar : PubMed/NCBI
|
20
|
Gao J, Zhu J, Li HY, Pan XY, Jiang R and
Chen JX: Small interfering RNA targeting integrin-linked kinase
inhibited the growth and induced apoptosis in human bladder cancer
cells. Int J Biochem Cell Biol. 43:1294–1304. 2011. View Article : Google Scholar : PubMed/NCBI
|
21
|
Liu Q, Xiao L, Yuan D, Shi X and Li P:
Silencing of the inte-grin-linked kinase gene induces the apoptosis
in ovarian carcinoma. J Recept Signal Transduct Res. 32:120–127.
2012. View Article : Google Scholar : PubMed/NCBI
|
22
|
Guo X, Wang W, Hu J, Feng K, Pan Y, Zhang
L and Feng Y: Lentivirus-mediated RNAi knockdown of NUPR1 inhibits
human nonsmall cell lung cancer growth in vitro and in vivo. Anat
Rec (Hoboken). 295:2114–2121. 2012. View
Article : Google Scholar
|
23
|
Xing Y, Qi J, Deng S, Wang C, Zhang L and
Chen J: Small interfering RNA targeting ILK inhibits metastasis in
human tongue cancer cells through repression of
epithelial-to-mesenchymal transition. Exp Cell Res. 319:2058–2072.
2013. View Article : Google Scholar : PubMed/NCBI
|
24
|
Federico Maurizio: Lentivirus Gene
Engineering Protocols (Methods in Molecular Biology). Humana Press;
229. pp. 69–85. 2003
|
25
|
Zheng YP, Liu H, Zeng H, Xiong L, Feng ZH
and Sun NX: Downregulation of lentivirus-mediated ILK RNAi on
tractional force generation in human retinal Müller cells. Acta
Pharmacol Sin. 30:1625–1633. 2009. View Article : Google Scholar : PubMed/NCBI
|
26
|
Leong DT, Gupta A, Bai HF, Wan G, Yoong
LF, Too HP, Chew FT and Hutmacher DW: Absolute quantification of
gene expression in biomaterials research using real-time PCR.
Biomaterials. 28:203–210. 2007. View Article : Google Scholar
|
27
|
Choi S and Myers JN: Molecular
pathogenesis of oral squamous cell carcinoma: Implications for
therapy. J Dent Res. 87:14–32. 2008. View Article : Google Scholar
|
28
|
Qiao B, Johnson NW and Gao J:
Epithelial-mesenchymal transition in oral squamous cell carcinoma
triggered by transforming growth factor-β1 is Snail
family-dependent and correlates with matrix metalloproteinase-2 and
-9 expressions. Int J Oncol. 37:663–668. 2010.PubMed/NCBI
|
29
|
Voulgari A and Pintzas A:
Epithelial-mesenchymal transition in cancer metastasis: Mechanisms,
markers and strategies to overcome drug resistance in the clinic.
Biochim Biophys Acta. 1796:75–90. 2009.PubMed/NCBI
|
30
|
Araki K, Shimura T, Suzuki H, Tsutsumi S,
Wada W, Yajima T, Kobayahi T, Kubo N and Kuwano H: E/N-cadherin
switch mediates cancer progression via TGF-β-induced
epithelial-to-mesenchymal transition in extrahepatic
cholangio-carcinoma. Br J Cancer. 105:1885–1893. 2011. View Article : Google Scholar : PubMed/NCBI
|
31
|
Shin SY, Rath O, Zebisch A, Choo SM, Kolch
W and Cho KH: Functional roles of multiple feedback loops in
extracellular signal-regulated kinase and Wnt signaling pathways
that regulate epithelial-mesenchymal transition. Cancer Res.
70:6715–6724. 2010. View Article : Google Scholar : PubMed/NCBI
|
32
|
Peinado H, Portillo F and Cano A:
Transcriptional regulation of cadherins during development and
carcinogenesis. Int J Dev Biol. 48:365–375. 2004. View Article : Google Scholar : PubMed/NCBI
|
33
|
Peinado H, Olmeda D and Cano A: Snail, Zeb
and bHLH factors in tumour progression: An alliance against the
epithelial phenotype? Nat Rev Cancer. 7:415–428. 2007. View Article : Google Scholar : PubMed/NCBI
|
34
|
Radeva G, Petrocelli T, Behrend E,
Leung-Hagesteijn C, Filmus J, Slingerland J and Dedhar S:
Overexpression of the integrin-linked kinase promotes
anchorage-independent cell cycle progression. J Biol Chem.
272:13937–13944. 1997. View Article : Google Scholar : PubMed/NCBI
|
35
|
Persad S, Attwell S, Gray V, Delcommenne
M, Troussard A, Sanghera J and Dedhar S: Inhibition of
integrin-linked kinase (ILK) suppresses activation of protein
kinase B/Akt and induces cell cycle arrest and apoptosis of
PTEN-mutant prostate cancer cells. Proc Natl Acad Sci USA.
97:3207–3212. 2000. View Article : Google Scholar : PubMed/NCBI
|
36
|
D'Amico M, Hulit J, Amanatullah DF,
Zafonte BT, Albanese C, Bouzahzah B, Fu M, Augenlicht LH, Donehower
LA, Takemaru K, et al: The integrin-linked kinase regulates the
cyclin D1 gene through glycogen synthase kinase 3beta and
cAMP-responsive element-binding protein-dependent pathways. J Biol
Chem. 275:32649–32657. 2000. View Article : Google Scholar : PubMed/NCBI
|
37
|
Fielding AB, Dobreva I, McDonald PC,
Foster LJ and Dedhar S: Integrin-linked kinase localizes to the
centrosome and regulates mitotic spindle organization. J Cell Biol.
180:681–689. 2008. View Article : Google Scholar : PubMed/NCBI
|
38
|
Fielding AB, Lim S, Montgomery K, Dobreva
I and Dedhar S: A critical role of integrin-linked kinase, ch-TOG
and TACC3 in centrosome clustering in cancer cells. Oncogene.
30:521–534. 2011. View Article : Google Scholar
|
39
|
Fielding AB and Dedhar S: The mitotic
functions of integrin-linked kinase. Cancer Metastasis Rev.
28:99–111. 2009. View Article : Google Scholar : PubMed/NCBI
|
40
|
Koul D, Shen R, Bergh S, Lu Y, de Groot
JF, Liu TJ, Mills GB and Yung WK: Targeting integrin-linked kinase
inhibits Akt signaling pathways and decreases tumor progression of
human glioblastoma. Mol Cancer Ther. 4:1681–1688. 2005. View Article : Google Scholar : PubMed/NCBI
|
41
|
Doble BW and Woodgett JR: Role of glycogen
synthase kinase-3 in cell fate and epithelial-mesenchymal
transitions. Cells Tissues Organs. 185:73–84. 2007. View Article : Google Scholar : PubMed/NCBI
|
42
|
Kalra J, Sutherland BW, Stratford AL,
Dragowska W, Gelmon KA, Dedhar S, Dunn SE and Bally MB: Suppression
of Her2/neu expression through ILK inhibition is regulated by a
pathway involving TWIST and YB-1. Oncogene. 29:6343–6356. 2010.
View Article : Google Scholar : PubMed/NCBI
|
43
|
Muramatsu M, Yamamoto S, Osawa T and
Shibuya M: Vascular endothelial growth factor receptor-1 signaling
promotes mobilization of macrophage lineage cells from bone marrow
and stimulates solid tumor growth. Cancer Res. 70:8211–8221. 2010.
View Article : Google Scholar : PubMed/NCBI
|